Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 1987; Volume 241,Issue 1
  • You have access
    Salutary effects of prostaglandin E1 in perfused rat lungs injured with hydrogen peroxide.
    M N Gillespie, C G Moore, C E Wright and W N O'Connor
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 1-5;
  • You have access
    Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    R J Shebuski, T Fujita, J M Smith and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 6-12;
  • You have access
    Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
    H Drexler, J W Depenbusch, A G Truog, R Zelis and S F Flaim
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 13-19;
  • You have access
    Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    N Imai, C S Liang, C K Stone, J S Hayes and W B Hood
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 20-26;
  • You have access
    Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    J F Bowyer and N Weiner
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 27-33;
  • You have access
    Nonmuscarinic neurotoxicity of oxotremorine.
    J M Witkin, R Alvarado-Garcia, M A Lee and K M Witkin
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 34-41;
  • You have access
    Tyramine neurotoxicity and first-pass brain technetium-99m-diethylenetriamine penta-acetic acid.
    B A Faraj, F H Schmidt, R Sarper, V M Camp and E Malveaux
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 42-47;
  • You have access
    Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    J R Martin and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 48-55;
  • You have access
    Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application.
    T H Maren, A Bar-Ilan, K C Caster and A R Katritzky
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 56-63;
  • You have access
    Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein.
    S T O'Rourke and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 64-67;
  • You have access
    Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate in the rat.
    J M O'Donnell
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 68-75;
  • You have access
    Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.
    V L Coffin and R D Spealman
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 76-83;
  • You have access
    Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    K A Thompson, I A Blair, R L Woosley and D M Roden
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 84-90;
  • You have access
    Calcium channel blockers: correlation among receptor binding, calcium uptake and contractility in vitro.
    S Papaioannou, S Panzer-Knodle and P C Yang
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 91-96;
  • You have access
    Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
    J F DiJoseph, J R Eash and G N Mir
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 97-102;
  • You have access
    In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    V J Lotti, R G Pendleton, R J Gould, H M Hanson, R S Chang and B V Clineschmidt
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 103-109;
  • You have access
    Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    R G Pendleton, R J Bendesky, L Schaffer, T E Nolan, R J Gould and B V Clineschmidt
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 110-116;
  • You have access
    REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile.
    R G Van Inwegen, A Khandwala, R Gordon, P Sonnino, S Coutts and S Jolly
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 117-124;
  • You have access
    Molecular mechanisms of corticotropin-releasing factor stimulation of calcium mobilization and adrenocorticotropin release from anterior pituitary tumor cells.
    S Guild and T Reisine
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 125-130;
  • You have access
    Effects of activation of sodium and calcium entry on spontaneous release of acetylcholine induced by methylmercury.
    W D Atchison
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 131-139;
  • You have access
    [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
    J G Sarmiento, A V Shrikhande, R A Janis and D J Triggle
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 140-146;
  • You have access
    Discriminative stimulus properties of lisuride revisited: involvement of dopamine D2 receptors.
    K A Cunningham, P M Callahan and J B Appel
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 147-151;
  • You have access
    Pharmacology of the enantiomers of threo-methylphenidate.
    K S Patrick, R W Caldwell, R M Ferris and G R Breese
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 152-158;
  • You have access
    Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination.
    P M Beardsley, R L Balster and J M Salay
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 159-165;
  • You have access
    Renal handling of netilmicin in the rat with streptozotocin-induced diabetes mellitus.
    E Pastoriza-Munoz, C Josepovitz, L Ramsammy and G J Kaloyanides
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 166-173;
  • You have access
    Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
    G A Kopia, R E Valocik, T J Torphy, L B Cieslinksi, H M Sarau, J J Foley and M A Wasserman
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 174-180;
  • You have access
    Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by ethylcholine aziridinium ion (AF64A) infused intraventricularly.
    C Eva, M Fabrazzo and E Costa
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 181-186;
  • You have access
    Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
    G A Ordway, J M O'Donnell and A Frazer
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 187-195;
  • You have access
    Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
    J Wolfe, M S Kreider, C Goodman and D J Brunswick
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 196-203;
  • You have access
    Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
    P W Kalivas and P Duffy
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 204-212;
  • You have access
    Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
    W L Woolverton, J B Kamien and L I Goldberg
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 213-217;
  • You have access
    Chemotactic peptide stimulation of leukotrienes from healthy and inflamed rabbit colons.
    R D Zipser, J B Patterson and L E Leduc
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 218-222;
  • You have access
    Effects of N6-(L-phenylisopropyl)adenosine, caffeine, theophylline and rolipram on the acquisition of conditioned responses in the rabbit.
    L Winsky and J A Harvey
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 223-229;
  • You have access
    Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    T W Mittag, A Tormay and S M Podos
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 230-235;
  • You have access
    Kinetics of drug action in disease states. XIX. Effect of experimental liver disease on the neurotoxicity of theophylline in rats.
    I M Ramzan, M Yasuhara and G Levy
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 236-238;
  • You have access
    Variation in sensitivity of alpha adrenoceptor-mediated contraction of the vascular smooth muscle of rabbit elastic and muscular arteries is related to receptor affinity.
    M A Oriowo, J A Bevan and R D Bevan
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 239-244;
  • You have access
    Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    K G Lloyd, B Zivkovic, D Sanger, H Depoortere and G Bartholini
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 245-250;
  • You have access
    Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.
    B Scatton, K G Lloyd, B Zivkovic, T Dennis, Y Claustre, J Dedek, S Arbilla, S Z Langer and G Bartholini
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 251-257;
  • You have access
    The 5-hydroxytryptamine (5-HT2) receptor stimulates inositol phosphate formation in intact and broken WRK1 cells: determination of occupancy-response relationships for 5-HT agonists.
    R N Cory, B Rouot, G Guillon, F Sladeczek, M N Balestre and J Bockaert
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 258-267;
  • You have access
    Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    D de Wied, O Gaffori, J P Burbach, G L Kovács and J M van Ree
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 268-274;
  • You have access
    Interval-dependent effects of lidocaine on conduction in canine cardiac Purkinje fibers: experimental observations and theoretical analysis.
    S Nattel
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 275-281;
  • You have access
    Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    S Nattel
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 282-288;
  • You have access
    Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.
    A F De Rick, F M Belpaire, C Dello and M G Bogaert
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 289-293;
  • You have access
    Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein.
    K Ikezono, H R Zerkowski, J J Beckeringh, M C Michel and O E Brodde
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 294-299;
  • You have access
    Stereoselective disposition of methylphenidate in children with attention-deficit disorder.
    N R Srinivas, D Quinn, J W Hubbard and K K Midha
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 300-306;
  • You have access
    Nitrite conversion to nitric oxide in red cells and its stabilization as a nitrosylated valency hybrid of hemoglobin.
    R Kruszyna, H Kruszyna, R P Smith, C D Thron and D E Wilcox
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 307-313;
  • You have access
    Decreased vascular resistance after intra-arterial injection of [met]enkephalin in the hindquarters of conscious rabbits.
    J M Wightman, J C Schadt and R R Gaddis
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 314-320;
  • You have access
    Interactions of metaphit with phencyclidine and sigma agonist actions in rat cerebellum: determination of specificity and selectivity.
    Y Wang, M B Kim and M R Palmer
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 321-327;
  • You have access
    Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    L G Latimer, P Duffy and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 328-337;
  • You have access
    Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    D L Commins, G Vosmer, R M Virus, W L Woolverton, C R Schuster and L S Seiden
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 338-345;
  • You have access
    Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex.
    N L Harrison, M D Majewska, J W Harrington and J L Barker
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 346-353;
  • You have access
    Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma.
    J S Rosenbaum, R Ginsburg, M E Billingham and B B Hoffman
    Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 354-360;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 241, Issue 1
1 Apr 1987
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics